NASDAQ:YTEN Yield10 Bioscience (YTEN) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free YTEN Stock Alerts $0.24 +0.00 (+1.49%) (As of 02:39 PM ET) Add Compare Share Share Today's Range$0.22▼$0.2450-Day Range$0.22▼$0.4352-Week Range$0.18▼$3.29Volume192,870 shsAverage Volume4.00 million shsMarket Capitalization$3.67 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Yield10 Bioscience alerts: Email Address Yield10 Bioscience MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside1,358.3% Upside$3.50 Price TargetShort InterestHealthy1.42% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.69Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.17 out of 5 stars 3.2 Analyst's Opinion Consensus RatingYield10 Bioscience has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageYield10 Bioscience has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.42% of the outstanding shares of Yield10 Bioscience have been sold short.Short Interest Ratio / Days to CoverYield10 Bioscience has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Yield10 Bioscience has recently decreased by 76.80%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldYield10 Bioscience does not currently pay a dividend.Dividend GrowthYield10 Bioscience does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for YTEN. Previous Next 3.7 News and Social Media Coverage News SentimentYield10 Bioscience has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Yield10 Bioscience this week, compared to 1 article on an average week.Search Interest8 people have searched for YTEN on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows6 people have added Yield10 Bioscience to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Yield10 Bioscience insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.10% of the stock of Yield10 Bioscience is held by insiders.Percentage Held by InstitutionsOnly 4.91% of the stock of Yield10 Bioscience is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Yield10 Bioscience is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Yield10 Bioscience is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Yield10 Bioscience Stock (NASDAQ:YTEN)Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.Read More YTEN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YTEN Stock News HeadlinesApril 25, 2024 | americanbankingnews.comYield10 Bioscience (YTEN) Set to Announce Earnings on FridayApril 19, 2024 | americanbankingnews.comYield10 Bioscience (NASDAQ:YTEN) Stock Price Passes Above 200 Day Moving Average of $0.27April 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.April 5, 2024 | finance.yahoo.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call TranscriptApril 3, 2024 | markets.businessinsider.comHold Recommendation on Yield10 Bioscience Amid Commercialization and Capital UncertaintiesApril 2, 2024 | finance.yahoo.comQ4 2023 Yield10 Bioscience Inc Earnings CallApril 1, 2024 | investorplace.comYTEN Stock Earnings: Yield10 Bioscience Beats EPS for Q4 2023April 1, 2024 | benzinga.comYield10 Bioscience: Q4 Earnings InsightsApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.April 1, 2024 | globenewswire.comYield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | globenewswire.comYield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024March 26, 2024 | globenewswire.comYield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in CanadaMarch 23, 2024 | stockhouse.comUSDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United StatesMarch 21, 2024 | markets.businessinsider.comDow Jumps 200 Points; US Weekly Jobless Claims FallMarch 21, 2024 | markets.businessinsider.comUSDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United StatesMarch 21, 2024 | msn.comYield10 stock soars 120% on USDA okay for Camelina plantingMarch 21, 2024 | finance.yahoo.comUSDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United StatesMarch 21, 2024 | investorplace.comWhy Is Yield10 (YTEN) Stock Up 117% Today?March 21, 2024 | globenewswire.comUSDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United StatesMarch 10, 2024 | barrons.comYield10 Bioscience Inc.February 29, 2024 | globenewswire.comYield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field TestsFebruary 14, 2024 | finance.yahoo.comYield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel FeedstockFebruary 14, 2024 | globenewswire.comYield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel FeedstockFebruary 9, 2024 | msn.comYield10 Bioscience Accelerates Omega-3 Camelina LaunchFebruary 9, 2024 | finanznachrichten.deYield10 Bioscience, Inc.: Yield10 Bioscience Provides an Update on its Omega-3 Camelina ProgramFebruary 8, 2024 | realmoney.thestreet.comYield10 Bioscience just downgraded at Lake Street, here's whyFebruary 8, 2024 | msn.comWhat's Going On With Yield10 Bioscience (YTEN) Stock?See More Headlines Receive YTEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/01/2024Today4/25/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural production - crops Sub-IndustryN/A Current SymbolNASDAQ:YTEN CUSIPN/A CIK1121702 Webwww.yield10bio.com Phone(617) 583-1700Fax617-583-1768Employees29Year Founded1992Price Target and Rating Average Stock Price Target$3.50 High Stock Price Target$4.00 Low Stock Price Target$3.00 Potential Upside/Downside+1,421.1%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($2.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,450,000.00 Net MarginsN/A Pretax Margin-24,091.67% Return on Equity-888.81% Return on Assets-273.34% Debt Debt-to-Equity RatioN/A Current Ratio0.29 Quick Ratio0.29 Sales & Book Value Annual Sales$60,000.00 Price / Sales59.06 Cash FlowN/A Price / Cash FlowN/A Book Value($0.21) per share Price / Book-1.10Miscellaneous Outstanding Shares15,400,000Free Float14,462,000Market Cap$3.54 million OptionableNot Optionable Beta1.58 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Oliver P. Peoples Ph.D. (Age 66)Co-Founder, President, CEO & Director Comp: $344.48kDr. Anthony J. Sinskey Ph.D. (Age 84)Sc.D., Co-Founder & Independent Director Comp: $62.5kDr. Kristi D. Snell (Age 56)VP of Research & Chief Science Officer Comp: $278.69kMs. Lynne H. Brum (Age 60)VP of Planning & Corporate Communications and Secretary Comp: $278.69kMr. Charles B. Haaser (Age 68)VP of Finance, Chief Accounting Officer & Treasurer Comp: $236.41kDr. Nicholas Renegar Ph.D.Director of Business Analytics & OperationsMore ExecutivesKey CompetitorsAfrican AgricultureNASDAQ:AAGREdible GardenNASDAQ:EDBLReborn CoffeeNASDAQ:REBNStryve FoodsNASDAQ:SNAXInspire Veterinary PartnersNASDAQ:IVPView All CompetitorsInsidersJack W SchulerSold 36,000 sharesTotal: $7,560.00 ($0.21/share)Jack W SchulerSold 35,000 sharesTotal: $8,400.00 ($0.24/share)Jack W SchulerSold 37,931 sharesTotal: $11,379.30 ($0.30/share)Jack W SchulerSold 41,399 sharesTotal: $12,833.69 ($0.31/share)Jack W SchulerBought 765,000 shares on 8/15/2023Total: $497,250.00 ($0.65/share)View All Insider Transactions YTEN Stock Analysis - Frequently Asked Questions Should I buy or sell Yield10 Bioscience stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" YTEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in YTEN, but not buy additional shares or sell existing shares. View YTEN analyst ratings or view top-rated stocks. What is Yield10 Bioscience's stock price target for 2024? 3 equities research analysts have issued 1 year price objectives for Yield10 Bioscience's stock. Their YTEN share price targets range from $3.00 to $4.00. On average, they expect the company's stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 1,358.3% from the stock's current price. View analysts price targets for YTEN or view top-rated stocks among Wall Street analysts. How have YTEN shares performed in 2024? Yield10 Bioscience's stock was trading at $0.2393 at the beginning of 2024. Since then, YTEN shares have increased by 0.3% and is now trading at $0.24. View the best growth stocks for 2024 here. Are investors shorting Yield10 Bioscience? Yield10 Bioscience saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 218,300 shares, a decrease of 76.8% from the March 31st total of 940,900 shares. Based on an average trading volume of 4,900,000 shares, the short-interest ratio is presently 0.0 days. View Yield10 Bioscience's Short Interest. When is Yield10 Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our YTEN earnings forecast. How were Yield10 Bioscience's earnings last quarter? Yield10 Bioscience, Inc. (NASDAQ:YTEN) issued its earnings results on Monday, April, 1st. The specialty chemicals company reported ($0.27) EPS for the quarter. When did Yield10 Bioscience's stock split? Yield10 Bioscience shares reverse split before market open on Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 15th 2020. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of Yield10 Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD). How do I buy shares of Yield10 Bioscience? Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:YTEN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yield10 Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
